EPIDEMIOLOGY, RESOURCE DISTRIBUTION, AND MANAGEMENT CHALLENGES OF CHRONIC HEART FAILURE IN KAZAKHSTAN: A NATIONAL RETROSPECTIVE ANALYSIS
Background. Chronic heart failure is a growing global health challenge, particularly in Kazakhstan, where demographic changes and rising numbers of comorbidities are worsening the burden. However, data on CHF prevalence, diagnosis and healthcare resource distribution in the regions remain limited.
This study aims to assess and compare the epidemiological trends, regional disparities and healthcare system capacity of CHF in Kazakhstan based on recent national data.
Materials and methods. A retrospective analysis was conducted using national healthcare records from 2023–2024, including chronic heart failure prevalence, new diagnoses, stage distribution, regional healthcare resources and surgical interventions of patients. The Gini index was used to evaluate regional disparities, along with other statistical analyses.
Results. In 2024, 87,260 patients were examined, with a 19% increase from 2023. Of 12,874 new cases, 75.6% were identified in early stages (A and B), suggesting progress in early detection. However, regional disparities were severe, with Gini indices for ProBNP testing and echocardiography at 0.556 and 0.480, respectively. High-resource areas like Almaty contrasted sharply with under-resourced regions such as Mangystau and Kyzylorda wtih heart transplants being declined, while LVAD usage increasing which reflects evolving treatment patterns amid limited donor availability.
Conclusion. Chronic heart failure is increasing in Kazakhstan amid significant regional and systemic inequalities in care. Targeted interventions with improved diagnostic access, equitable resource allocation, and national policy reform are urgently needed to manage the growing burden and improve outcomes of patients across the country
Makhabbat S. Bekbossynova - Associated Professor, Deputy Chairman of the Management Board, cardiologist, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, cardiacsurgeryres@gmail.com, https://orcid.org/0000-0003-2834-617X ; 8 (7172) 70 31 00
Aliya I. Sailybaeva - Chief of Research Department, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, s.aliya@umc.org.kz, https://orcid.org/0000-0002-1489-3837 ; +7 701 795 17 76
Gulden A. Kabduyeva - Manager in Research Department, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, cardiacsurgeryres@gmail.com, https://orcid.org/0009-0007-1435-1177 +7 778 000 13 06
Saltanat K. Jetybayeva - Cardiologist,“University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, cardiacsurgeryres@gmail.com, https://orcid.org/0000-0003-3442-3223
Ainur T. Tauekelova - Cardiologist, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, a.tauekelova@umc.org.kz,https://orcid.org/0000-0002-4237-9835
Svetlana P. Novikova - Cardiac surgeon, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, cardiacsurgeryres@gmail.com, https://orcid.org/0000-0001-8161 -7712
Gulzhan Sh. Myrzakhmetova - Chief of Cardiology Department 2, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, mgsh2000@mail.ru, https://orcid.org/0000-0001-8325-1267
Zhadyra S. Duisenbina - Doctor, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, cardiacsurgeryres@gmail.com, https://orcid.org/0009-0006-1801-009X
Aiym Sakhipova - Neuropathist, “University Medical Center” Corporate Fund, Astana, Kazakhstan, Turan avenue, 38, cardiacsurgeryres@gmail.com, https://orcid.org/0000-0002-0507-6704
Kamila T. Akzholova - Doctor of Medicine program student, Nazarbayev University, School of Medicine, kamila.akzholova@nu.edu.kz, https://orcid.org/0009-0000-2527-8947 ; +7 707 489 84 78
Almagul R. Kushugulova - Head of the Microbiome Laboratory at the Center for Life Sciences of the C.U. National Laboratory Astana, akushugulova@nu.edu.kz https://orcid.org/0000-0001-9479-0899
1. Bashirov Ansar. Chronic Heart Failure Epidemiology In Kazakhstan And Other Countries. Ulyanovsk Medico-biological Journal, 2024. 17–27. DOI: 10.34014/2227-1848-2024-3-17-27
2. Bekbossynov S., Medressova A., Murzagaliyev M., Salov R., Dzhetybayeva S., Andossova S., Bekbossynova M., Pya Y. Surgical heart failure treatment program – the experience of Kazakhstan. Giornale Italiano di Cardiologia, 2014. 15(3).
3. Benjamin E.J., Muntner P., Alonso A. et al. Heart Disease and Stroke Statistics - 2019 Update: A Report From the American Heart Association. Circulation, 2019. 139(10). DOI: 10.1161/CIR.0000000000000659
4. Cho J.H. Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction. Korean Circ J, 2022. 52(4), 251. DOI: 10.4070/kcj.2021.0420
5. Conrad Nathalie et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. The Lancet, 2018. 391(10120), 572–580.
6. Curtis L.H., Whellan D.J., Hammill B.G., Hernandez A.F., Anstrom K.J., Shea A.M., Schulman K.A. Incidence and prevalence of heart failure in elderly persons, 1994–2003. Arch Intern Med, 2008. 168, 418–424.
7. Global Burden of Disease Study 2015 (GBD 2015) results. Seattle, WA: Institute for Health Metrics and Evaluation (IHME), University of Washington; 2016.
8. Groenewegen A., Rutten F.H., Mosterd A., & Hoes, A.W.. Epidemiology of heart failure. Eur J Heart Fail, 2020. 22, 1342–1356. https://doi.org/10.1002/ejhf.1858
9. Haydock P.M., Flett A.S. Management of heart failure with reduced ejection fraction. Heart, 2022. 108(19), 1571–1579. DOI: 10.1136/heartjnl-2020-318811
10. Inamdar A.A., & Inamdar A.C. Heart failure: Diagnosis, management and utilization. J Clin Med, 2016. 5(7). DOI: 10.3390/jcm5070062
11. National Scientific Cardiac Surgery Center. Chronic heart failure: Methodological recommendations. Astana: National Scientific Cardiac Surgery Center. 2022.
12. Norhammar - Bodegard J., Vanderheyden M. et al. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. Published online February 13, 2023. DOI: 10.1136/heartjnl-2022-321702
13. Pfeffer M.A., Shah A.M., Borlaug B.A. Heart failure with preserved ejection fraction in perspective. Circ Res 2019., 124, 1598–1617.
14. Pieske B., Tschöpe C., De Boer R.A. et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm. Eur Heart J., 2019. 40, 3297–3317.
15. Ponikowski P., Voors A.A., Anker S.D. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail, 2016. 18, 891–975.
16. Semenova Y., Shaisultanova S., Beyembetova A. et al. Examining a 12-year experience within Kazakhstan’s national heart transplantation program. Scientific Reports, 2024.14(10291). https://doi.org/10.1038/s41598-024-61131-1
17. Statistical collection “Health of the population of the Republic of Kazakhstan and the activities of healthcare organizations in 2022–2023”
18. Tazhieva A.E., Khabizhanova V.B. Tuleutayeva S.A., Erlepesova A.T. Течение хронической сердечной недостаточности на фоне COVID-19, обзорный анализ. Pharmaceutical Kazakhstan, 2024. 22(45), 118–122. https://doi.org/10.53511/pharmkaz.2024.22.45.014
19. Townsend N., Bhatnagar P., Wilkins E., Wickramasinghe K., Rayner M. Cardiovascular disease statistics. London: British Heart Foundation, 2015.
20. Zhakhina G., Gusmanov A., Sakko Y., Yerdessov, S., Mussina K., Gaipov A. Burden of heart failure in Kazakhstan: data from the unified national healthcare system 2014–2021. European Journal of Public Health, 2023. 33. https://doi.org/10.1093/eurpub/ckad160.1274
Количество просмотров: 15
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Bekbossynova M.S., Sailybaeva A.I., Kabduyeva G.A., Jetybayeva S.K., Tauekelova A.T., Novikova S.P., Myrzakhmetova G.Sh., Duisenbina Zh.S., Sakhipova A., Akzholova K.T., Kushugulova A.R. Epidemiology, Resource Distribution, and Management Challenges of Chronic Heart Failure in Kazakhstan: A National Retrospective Analysis // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (3), pp. 7-15. doi 10.34689/SH.2025.27.3.001Похожие публикации:
EPIDEMIOLOGY, RESOURCE DISTRIBUTION, AND MANAGEMENT CHALLENGES OF CHRONIC HEART FAILURE IN KAZAKHSTAN: A NATIONAL RETROSPECTIVE ANALYSIS
ANALYSIS OF SOCIO-DEMOGRAPHIC DETERMINANTS AND RISK FACTORS OF TUBERCULOSIS IN THE ABAI REGION DURING THE PERIOD 2014–2022
ANALYSIS OF ANTIBIOTIC SUSCEPTIBILITY AND RESISTANCE OF KLEBSIELLA PNEUMONIAE IN VARIOUS BIOLOGICAL MATERIALS
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF BRONCHIAL ASTHMA IN CHILDREN AND ADOLESCENTS IN THE ABAY REGION
VIRAL HEPATITIS IN KAZAKHSTAN: REGIONAL EPIDEMIOLOGICAL OVERVIEW